Abstract

Pharmacological profile of MK-8189, a novel phosphodiesterase 10A inhibitor, and relationship between phosphodiesterase 10A enzyme occupancy and preclinical efficacy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call